logo
CanyamAI summaries for academic research
language
MobileMobile
  • Phone FeatureWeChat Mini Program
EnglishEnglish
noticeNotice
BlogBlog
delete
arrow
Back
B

Bert H. O’Neil

community health network

60H-index
462Paper Count
1.7WCitation Count
Published Papers 90
Publication Date
logo
Subcutaneous delivery of amivantamab in patients with advanced solid malignancies: the phase 1b PALOMA study
errClinical Lung Cancer
IF3.3
err2026-02-03
err0
PREAI
errAnna Minchom; Byoung Chul Cho; Natasha B Leighl; Melissa L Johnson; Joshua Sabari; Se-Hoon Lee; Ki Hyeong Lee; Yu Jung Kim; Rachel E Sanborn; Bert O’Neil; Kamya Sankar; Anna Mitselos; Donna Zemlickis; Carmel Collins; Ali Alhadab; Pamela L Clemens; Busola Sanusi; Eileen Berkay; Mahadi Baig; Roland E Knoblauch
errShare
errSave
A Phase I study targeting the APE1/ref-1 redox signaling protein with APX3330: First clinical agent targeting APE1/ref-1 in Cancer
errThe Oncologist
IF0
err2025-12-19
err0
errOAAI
errMark R Kelley; Jun Wan; Sheng Liu; Eyram Kpenu; Randall Wireman; Amber L Mosley; Hao Liu; Nehal J Lakhani; Safi Shahda; Bert O’Neil; Mateusz Opyrchal; Richard A Messmann
errShare
errSave
Outcomes for FOLFIRI plus bevacizumab or cetuximab in patients treated with oxaliplatin-based adjuvant therapy: a combined analysis of FIRE-3 and CALGB/SWOG 80405 (Alliance)
errEuropean Journal of Cancer
IF7.1
err2025-08-05
err0
PREAI
errFrancesca Battaglin; Bert H O'Neil; Sebastian Stintzing; Fang-Shu Ou; Tyler J Zemla; Donna Niedzwiecki; Federico Innocenti; Howard S Hochster; Ludwig Fischer von Weikersthal; Thomas Decker; Alexander Kiani; Ursula Vehling-Kaiser; Tobias Heintges; Christian Lerchenmüller; Lena Weiss; Kathrin Heinrich; Richard M Goldberg; Robert J Mayer; Richard L Schilsky; Charles D Blanke; Alan P Venook; Heinz-Josef Lenz; Volker Heinemann
errShare
errSave
First-in-human study of AMG 193, an MTA-cooperative PRMT5 inhibitor, in patients with MTAP-deleted solid tumors: results from phase I dose exploration5
errANNALS OF ONCOLOGY
IF65.4
err2024-12-01
err4
PREAI
errRodon, J.; Prenen, H.; Sacher, A.; Villalona-Calero, M.; Penel, N.; El Helali, A.; Rottey, S.; Yamamoto, N.; Ghiringhelli, F.; Goebeler, M. E.; Doi, T.; Postel-Vinay, S.; Lin, C. -c.; Liu, C.; Chuang, C. -h.; Keyvanjah, K.; Eggert, T.; Neil, B. h. o '
errShare
errSave
Type II RAF inhibitor tovorafenib in recurrent/refractory (R/R) melanoma or other solid tumors with RAF fusions and/or RAF1 amplification
errANNALS OF ONCOLOGY
IF65.4
err2024-09-01
err1
PREAI
errVieito, M.; Garralda, E.; Mehmi, I.; Marqueste, C. Gaudy; O'Neil, B. H.; Medina, T. M.; Body, A.; Arance, A. M.; Kummar, S.; Najjar, Y. G.; Bedard, P. L.; Chu, C.; McKenna, C.; Hume, S.; Kopp, L. M.; Lee, J.
errShare
errSave
Impact of AI clinical trial program on screening, matching, and enrollment of patients over 6 months
errANNALS OF ONCOLOGY
IF65.4
err2024-09-01
err0
PREAI
errShepard, D.; Mallahan, S.; Osterman, C.; Skelly, D.; Patnaude, E.; Weiss, M.; O'Neil, B. H.; Rao, A.; Abdulla, N. E.; Zarzour, A.; Sankhala, K. Kumar; Goldstein, M. G.; Parsons, B.; La Porte, P.; Franzen, A. G.; Cohen, E.; Cooney, M.
errShare
errSave
Phase II results of the porcupine (PORCN) inhibitor zamaporvint (RXC004) in genetically selected microsatellite stable colorectal cancer patients
errANNALS OF ONCOLOGY
IF65.4
err2024-06-01
err0
PREAI
errCook, N.; Bridgewater, J. A.; Saunders, M. P.; Kopetz, S.; Garcia-Carbonero, R.; Beom, S-H.; O'Neil, B. H.; Wilson, R. H.; Graham, J.; Maurel, J.; Kim, T. W.; Chau, I.; Saleha, S.; Goodwin, L.; Wilson, D.; Robertson, J.; Timmis, H.; Asken, E.; Woodcock, S. A.; Morris, V.
errShare
errSave
Common variation in a long non-coding RNA gene modulates variation of circulating TGF-β2 levels in metastatic colorectal cancer patients (Alliance)
errBMC GENOMICS
IF3.7
err2024-05-14
err0
errOAAI
errQuintanilha, Julia C. F.; Sibley, Alexander B.; Liu, Yingmiao; Niedzwiecki, Donna; Halabi, Susan; Rogers, Layne; O'Neil, Bert; Kindler, Hedy; Kelly, William; Venook, Alan; McLeod, Howard L.; Ratain, Mark J.; Nixon, Andrew B.; Innocenti, Federico; Owzar, Kouros
errShare
errSave
A first-inhuman study of the highly selective PI3Ka inhibitor RLY-5836 in patients with advanced breast cancer and other solid tumors
errCANCER RESEARCH
IF16.6
err2024-05-02
err0
PREAI
errVarkaris, Andreas; Isakoff, Steven; Perez, Cesar A.; O'Neil, Bert; Hamilton, Erika; Conlin, Erin; Tan, Gege; Li, Xiaoyan; Timm, Alison; Samadani, Ramin; Puente-Poushnejad, Erika; Kwak, Eunice; Mar, Brenton G.; Schram, Alison M.
errShare
errSave
A meta-analysis of efficacy and safety data from head-to-head first-line trials of epidermal growth factor receptor inhibitors versus bevacizumab in adult patients with RAS wild-type metastatic colorectal cancer by sidedness
errEUROPEAN JOURNAL OF CANCER
IF7.1
err2024-05-01
err6
PREAI
errYoshino, Takayuki; Hooda, Naushin; Younan, Diana; Muro, Kei; Shitara, Kohei; Heinemann, Volker; O'neil, Bert Howard; Herrero, Fernando Rivera; Peeters, Marc; Soeda, Junpei; Suh, Mina; Reichert, Heidi; Mezzi, Khalid; Fryzek, Jon; Chia, Victoria; Rehn, Marko; Stintzing, Sebastian
errShare
errSave
Initial results from first-in-human study of AMG 193, an MTA-cooperative PRMT5 inhibitor, in biomarker-selected solid tumors
errMOLECULAR CANCER THERAPEUTICS
IF5.5
err2023-12-01
err8
PREAI
errRodon, Jordi; Yamamoto, Noboru; Doi, Toshihiko; Ghiringhelli, Francois; Goebeler, Maria-Elisabeth; Fujuwara, Yutaka; Villalona-Calero, Miguel; Penel, Nicolas; Patnaik, Amita; Machiels, Jean-Pascal; Addeo, Alfredo; Abbruzzese, James; Postel-Vinay, Sophie; Rottey, Sylvie; Liu, Chunxu; Chuang, Chen-Hua; Kormany, William; Hughes, Paul; Keyvanjah, Kiana; O'Neil, Bert
errShare
errSave
A meta-analysis of efficacy and safety from head-to-head first-line (1L) trials of epidermal growth factor receptor inhibitors (EGFRIs) versus bevacizumab in combination with chemotherapy (CT) doublets in patients with RAS wild-type (WT) metastatic colorectal cancer (mCRC) by sidedness
errANNALS OF ONCOLOGY
IF65.4
err2023-11-01
err0
PREAI
errYoshino, T.; Hooda, N.; Younan, D.; Muro, K.; Shitara, K.; Heinemann, V.; O'Neil, B.; Herrero, F. Rivera; Peeters, M.; Soeda, J.; Suh, M.; Reichart, H.; Mezzi, K.; Fryzek, J.; Chia, V.; Rehn, M.; Stintzing, S.
errShare
errSave
First-in-human study of SGN-B7H4V, a B7-H4-directed vedotin ADC, in patients with advanced solid tumors: Preliminary results of a phase I study (SGNB7H4V-001)
errANNALS OF ONCOLOGY
IF65.4
err2023-10-01
err3
errOAAI
errPerez, C. A.; Henry, J. T.; Lakhani, N.; Call, J. A.; Hamilton, E. P.; Colon-Otero, G.; Diamond, J. R.; O'Neil, B.; Kalyan, A.; Sonpavde, G. P.; Candilejo, I. Moreno; Awan, A. A.; Fontana, E.; Xu, P.; Zhang, F.; Nazarenko, N.; Patnaik, A.
errShare
errSave
Phase II randomised, double-blind study of mFOLFIRINOX plus ramucirumab versus mFOLFIRINOX plus placebo in advanced pancreatic cancer patients (HCRN GI14-198)
errEUROPEAN JOURNAL OF CANCER
IF7.1
err2023-08-01
err3
PREAI
errShaib, Walid L.; Manali, Rupji; Liu, Yuan; El-Rayes, Bassel; Loehrer, Patrick; O'Neil, Bert; Cohen, Steven; Khair, Tina; Robin, Erwin; Huyck, Timothy; Bekaii-Saab, Tanios
errShare
errSave
Pembrolizumab for previously treated, microsatellite instability-high/mismatch repair-deficient advanced colorectal cancer: final analysis of KEYNOTE-164
errEUROPEAN JOURNAL OF CANCER
IF7.1
err2023-06-01
err27
PREAI
errLe, Dung T.; Diaz Jr, Luis A.; Kim, Tae Won; Van Cutsem, Eric; Geva, Ravit; Jaeger, Dirk; Hara, Hiroki; Burge, Matthew; O'Neil, Bert H.; Kavan, Petr; Yoshino, Takayuki; Guimbaud, Rosine; Taniguchi, Hiroya; Elez, Elena; Al-Batran, Salah-Eddin; Boland, Patrick M.; Cui, Yi; Leconte, Pierre; Marinello, Patricia; Andre, Thierry
errShare
errSave
Age and comorbidity association with survival outcomes in metastatic colorectal cancer: CALGB 80405 analysis
errJOURNAL OF GERIATRIC ONCOLOGY
IF2.7
err2022-05-01
err3
errOAAI
errMcCleary, Nadine J.; Zhang, Sui; Ma, Chao; Ou, Fang-Shu; Bainter, Tiffany M.; Venook, Alan P.; Niedzwiecki, Donna; Lenz, Heinz-Josef; Innocenti, Federico; O'Neil, Bert H.; Polite, Blase N.; Hochster, Howard S.; Atkins, James N.; Goldberg, Richard M.; Ng, Kimmie; Mayer, Robert J.; Blanke, Charles D.; O'Reilly, Eileen M.; Fuchs, Charles S.; Meyerhardt, Jeffrey A.
errShare
errSave
A phase I evaluation of the effect of curcumin on dose-limiting toxicity and pharmacokinetics of irinotecan in participants with solid tumors
errCTS-CLINICAL AND TRANSLATIONAL SCIENCE
IF2.8
err2022-02-26
err17
errOAAI
errGbolahan, Olumide B.; O'Neil, Bert H.; McRee, Autumn J.; Sanoff, Hanna K.; Fallon, John K.; Smith, Philip C.; Ivanova, Anastasia; Moore, Dominic T.; Dumond, Julie; Asher, Gary N.
errShare
errSave
BRE12-158: A post-neoadjuvant, randomized phase 2 trial of personalized therapy vs. treatment of physician's choice for patients with residual triple negative breast cancer
errCANCER RESEARCH
IF16.6
err2022-02-15
err0
PREAI
errSchneider, Bryan P.; Jiang, Guanglong; Ballinger, Tarah J.; Shen, Fei; Chitambar, Christopher; Nanda, Rita; Falkson, Carla; Lynce, Filipa C.; Gallagher, Christopher; Isaacs, Claudine; Blaya, Marcelo; Paplomata, Elisavet; Walling, Radhika; Daily, Karen; Mahtani, Reshma; Thompson, Michael A.; Graham, Robert; Cooper, Maureen E.; Pavlick, Dean C.; Albacker, Lee A.; Gregg, Jeffery; Solzak, Jeffery P.; Chen, Yu-Hsiang; Bales, Casey L.; Cantor, Erica; Hancock, Bradley A.; Kassem, Nawal; Helft, Paul; O'Neil, Bert; Storniolo, Anna Maria; Badve, Sunil; Miller, Kathy D.; Radovich, Milan
errShare
errSave
Pembrolizumab (pembro) for previously treated, microsatellite instabilityehigh (MSI-H)/mismatch repair-deficient (dMMR) metastatic colorectal cancer (mCRC): Final analysis of KEYNOTE-164
errANNALS OF ONCOLOGY
IF65.4
err2021-09-01
err5
errOAAI
errLe, D. T.; Diaz, L.; Kim, T. W.; Van Cutsem, E.; Geva, R.; Jager, D.; Hara, H.; Burge, M.; O'Neil, B.; Kavan, P.; Yoshino, T.; Guimbaud, R.; Taniguchi, H.; Elez, E.; Al-Batran, S-E.; Boland, P.; Cui, Y.; Leconte, P.; Marinello, P.; Andre, T.
errShare
errSave
A Phase I Study of an IDO-1 Inhibitor (LY3381916) as Monotherapy and in Combination With an Anti-PD-L1 Antibody (LY3300054) in Patients With Advanced Cancer
errJOURNAL OF IMMUNOTHERAPY
IF2.9
err2021-04-27
err15
PREAI
errKotecki, Nuria; Vuagnat, Perrine; O'Neil, Bert H.; Jalal, Shadia; Rottey, Sylvie; Prenen, Hans; Benhadji, Karim A.; Xia, Meng; Szpurka, Anna M.; Saha, Abhijoy; Wallin, Johan; Suriyapperuma, Subha; Galvao, Violeta R.; Geeganage, Sandaruwan; Doman, Thompson N.; Gandhi, Leena; Xu, Xiaojian; Bendell, Johanna
errShare
errSave

Research Directions

No research directions
Co-authors
Cooperation Journals
E
Eric Van Cutsem
H-index: 174 · Papers: 1.8K
C
Charles S. Fuchs
H-index: 171 · Papers: 1.7K
J
Josep Tabernero
H-index: 146 · Papers: 2.7K
C
Charis Eng
H-index: 139 · Papers: 1.2K
H
Hope S. Rugo
H-index: 137 · Papers: 1.6K
View more